Preclinical evaluation of At-211-labeled trastuzumab, an alpha-particle radioimmunotherapeutic agent, for the treatment of gastric cancer.

2016 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []